Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (99)

11

Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection

enthalten in: HIV medicine | 2017

von Calza, L. | Colangeli, V. | Magistrelli, E. | +5

12

Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens

enthalten in: HIV medicine | 2017

von Armenia, D. | Di Carlo, D. | Maffongelli, G. | +17

13

Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial

enthalten in: HIV medicine | 2017

von Girard, P. | Antinori, A. | Arribas, J. | +5

14

Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women

enthalten in: HIV medicine | 2016

von Crauwels, H. | Kakuda, T. | Ryan, B. | +7

ErratumIn: HIV Med. 2019 Aug;20(7):496-499. - PMID 31318137

15

PEPDar : A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis

enthalten in: HIV medicine | 2016

von Fätkenheuer, G. | Jessen, H. | Stoehr, A. | +24

16

Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir

enthalten in: HIV medicine | 2016

von Rojas, J. | Lonca, M. | Imaz, A. | +12

17

Efficacy of protease inhibitor monotherapy vs. triple therapy : meta-analysis of data from 2303 patients in 13 randomized trials

enthalten in: HIV medicine | 2016

von Arribas, J. | Girard, P. | Paton, N. | +5

18

The ASSURE study : HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir

enthalten in: HIV medicine | 2016

von Wohl, D. | Bhatti, L. | Small, C. | +7

19

Lopinavir and atazanavir in pregnancy : comparable infant outcomes, virological efficacies and preterm delivery rates

enthalten in: HIV medicine | 2016

von Perry, M. | Taylor, G. | Sabin, C. | +18

20

The Intelence aNd pRezista Once A Day Study (INROADS) : a multicentre, single-arm, open-label study of etravirine and darunavir/ritonavir as dual therapy in HIV-1-infected early treatment-experienced subjects

enthalten in: HIV medicine | 2015

von Ruane, P. | Brinson, C. | Ramgopal, M. | +29